protein 670 words KG: SREBF2PROTEIN 2026-03-21
kind:proteinsection:proteinsstate:published
Contents

SREBF2 Protein — Sterol Regulatory Element Binding Factor 2 (SREBP-2)

🔬 Protein Info
Gene SymbolSREBF2
Full NameSterol Regulatory Element Binding Transcription Factor 2
AliasesSREBF2PROTEIN
Chromosome22
Protein TypeTranscription Factor
Target ClassTranscription Factor
FunctionSREBF2 plays a critical role in cholesterol metabolism, which is intimately connected to Alzheimer's disease pathogenesis through multiple mechanisms:
Mechanism of ActionSmall molecule modulators of transcriptional activity or protein-protein interactions
DruggabilityUndruggable (0.20)
Clinical StagePhase II
PathwaysAmyloid, Autophagy, Cholesterol, Cholesterol Metabolism, Mitophagy
UniProt IDA0AA34QVX2
Ensembl IDENSG00000198911
GeneCardsSREBF2
Human Protein AtlasSREBF2
Associated DiseasesALS, Alzheimer, neurodegeneration
Known Drugs/CompoundsRAPAMYCIN, rapamycin
InteractionsABCA1, LDLR, NFE2L2, C1Q, HTRA2, MTOR
SciDEX TargetView Target Profile (8 clinical trials)
KG Connections557 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (15)

Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.48
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Membrane Cholesterol Gradient Modulators
Score: 0.52
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51

Related Analyses (8)

Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived

Related Experiments (2)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40

See Also (15)

Neurodegeneration
disease · KG edge: implicated_in
Extracellular Vesicle and Tunneling Nanotube-Mediated S
mechanism · Pages share 5 hypotheses
ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 5 hypotheses
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 5 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 5 hypotheses